This section contains case studies, industry highlights, minireviews, and other articles for drug discovery professionals. Check out the resources page for posters, educational content, lists of drug approvals, and more.
We asked the global drug discovery community to nominate and vote on their favorite molecule from 2021, and the results…
Article
1 year ago ●
11 mins read
Context. SPH3127 (Mitsubishi Tanabe and Shanghai Pharmaceuticals) is an oral direct renin inhibitor (DRI) being developed for hypertension. The renin-angiotensin-aldosterone…
molecule
6 months ago ●
5 mins read
This article reviews the novel drugs approved by the FDA in February 2022. together with Dr. Naveed Yasin, Dr. Vinicius…
Article
1 year ago ●
6 mins read
Context. AZD4831 (AstraZeneca) is an oral covalent myeloperoxidase (MPO) inhibitor being developed for heart failure. Almost half of chronic heart…
molecule
6 months ago ●
5 mins read
GSK3640254, one of January 2022's Molecules of the Month, is an HIV maturation inhibitor and Ph. IIb clinical candidate (60-180…
Article
1 year ago ●
2 mins read
Context. “Compound 6” (Novartis) is a first-in-class YAP-TEAD protein-protein inhibitor. The TEAD transcription factor and its coactivator YAP and WWTR1/TAZ…
molecule
6 months ago ●
4 mins read
Load More
